Blog

Donnie Rizzo: A major leap forward in the field of Digital Pathology and AI

Photo taken from Donnie Rizzo/LinkedIn

May 1, 2024, 19:47

Donnie Rizzo: A major leap forward in the field of Digital Pathology and AI

Donnie Rizzo, Global Director at Pathology and Oncology at Quest Diagnostics, made the following post on LinkedIn:

“Exciting news! Today marks a major leap forward in the field of Digital Pathology and AI. With their potential to revolutionize precision medicine, I’m thrilled to announce our acquisition of PathAI Dx and our collaboration with PathAI. This partnership signifies our deep commitment to advancing healthcare through innovative technology. Together, we’re poised to unlock immense value for health systems, physicians, and most importantly, patients. Here’s to a future where technology enhances and saves lives.”

Additional information.
Source: Donnie Rizzo/LinkedIn
OncoDaily

AI artificial intelligence cancer Digital pathology Donnie Rizzo Future of Healthcare health systems Healthcare Advances Healthcare Innovation healthcare solutions Healthcare Technology medical advances Medical Breakthroughs Medical Collaboration Medical Innovation Medical Technology OncoDaily Oncology PathAI Dx Pathology patient care physicians Precision Medicine Precision Medicine Revolution Technology Partnership

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology